1 10-Phenanthroline monohydrate

CAS No. 5144-89-8

1 10-Phenanthroline monohydrate( Phenanthroline monohydrate )

Catalog No. M20870 CAS No. 5144-89-8

110-Phenanthroline monohydrate is an inhibitor of metallopeptidases inhibits zinc-dependent hydrolysis of Fa-Gly-Leu-NH2 by B. subtilis neutral protease and B. thermoproteolyticus thermolysin.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
50MG 33 In Stock
100MG 45 In Stock
200MG Get Quote In Stock
500MG 100 In Stock
1G 145 In Stock

Biological Information

  • Product Name
    1 10-Phenanthroline monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    110-Phenanthroline monohydrate is an inhibitor of metallopeptidases inhibits zinc-dependent hydrolysis of Fa-Gly-Leu-NH2 by B. subtilis neutral protease and B. thermoproteolyticus thermolysin.
  • Description
    110-Phenanthroline monohydrate is an inhibitor of metallopeptidases inhibits zinc-dependent hydrolysis of Fa-Gly-Leu-NH2 by B. subtilis neutral protease and B. thermoproteolyticus thermolysin.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Phenanthroline monohydrate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5144-89-8
  • Formula Weight
    198.22
  • Molecular Formula
    C12H10N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:39mg/mL(196.75mM)
  • SMILES
    O.c1cnc2c(c1)ccc1cccnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Feder J Garrett L R Kochavi D . Studies on the inhibition of neutral proteases by 110-phenanthroline[J]. Biochimica et Biophysica Acta 1971 235(2):370-377.
molnova catalog
related products
  • PG-116800

    PG-116800 (PG-530742) is a matrix metalloproteinase (MMP) inhibitor. PG-116800 can be used in studies about the treatment of osteoarthritis.

  • MMP-9-IN-7

    Acetamide, N-[2-[(5-chloro-2 methoxyphenyl)amino]-4'-methyl[4,5'-bithiazol]-2'-yl]-inhibits pro-matrix metalloproteinase activation and can be used to prevent, treat or ameliorate MMP9 and/or MMP13-mediated syndromes.

  • Incyclinide

    Incyclinide is a matrix metalloproteinase (MMP) inhibitor. Thereby causing extracellular matrix degradation, tumor growth and invasion, and inhibiting angiogenesis, and metastasis.